GlassScriptPhysician profile
Melanie Arora
NPI 1578889283
$603.58
in general payments reported to CMS, 2019-2025
15 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.89 · 2020: $12.18 · 2022: $76.01 · 2023: $144 · 2024: $173 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $235.97 | 2023-2025 | |
| Abbvie INC. | $57.49 | 2022-2023 | Orilissa, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $41.76 | 2025 | Myfembree |
| Sage Therapeutics, LLC | $34.22 | 2024 | |
| Baxter Healthcare | $33.62 | 2024-2025 | Perclot |
| Evofem Biosciences, INC. | $31.51 | 2022 | |
| Organon LLC | $23.17 | 2024 | |
| Hologic Sales and Service, LLC | $23.01 | 2024 | Thinprep 2000 Processor |
| Dexcom, INC. | $22.56 | 2023 | Dexcom G6 Transmitter |
| Exeltis, USA INC. | $21.42 | 2023 | Slynd |
| Roche Diagnostics Corporation | $18.86 | 2019 | |
| Medtronic, INC. | $18.64 | 2025 | Truclear |
| Vertex Pharmaceuticals Incorporated | $17.14 | 2025 | |
| Therapeuticsmd, INC. | $12.18 | 2020 | |
| Covidien LP | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.